DISTRIBUTION OF TOTAL BODY WATER AND FLUID DISTRIBUTION IN CRITICALLY ILL ELD

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 本研究的目的是设计一种基于多频生物电阻抗分析(MBIA)的基于全身水(TBW)的危重患者用药剂量的简单计算方法。这种相对较新的方法是一种非侵入性且简单的床边技术，可用于预测TBW、细胞外水(ECW)，并识别危重疾病后液体分布的变化。此外，我们还希望通过“金标准”示踪研究(氧化氢和溴化钠)来验证MBIA方法测量身体成分的有效性。用MBIA测量的TBW和ECW与使用氢稀释和溴化钠测量的结果在统计学上没有不同。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to design a simple method of calculating drug dosage in a critically ill patient based on total body water (TBW) using multifrequency bioelectrical impedance analysis (MBIA). This relatively new method is a noninvasive and simple bedside technique that can be used to predict TBW, extracellular water (ECW), and identify altered fluid distribution following critical illness. In addition, we would also like to perfrom "gold standard" tracer studies (deuterium oxide, and sodium bromide) to validate MBIA method of measuring body composition. TBW and ECW measured by MBIA will not be statistically different from measurements obtained using deuterium dilution and sodium bromide.